Variant report
Variant | esv3345130 |
---|---|
Chromosome Location | chr6:141712559-141715857 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531511793 | chr6:141712577-141712578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540622373 | chr6:141712638-141712639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560959304 | chr6:141712680-141712681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7763498 | chr6:141712734-141712735 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs543346078 | chr6:141712748-141712749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377030252 | chr6:141712758-141712759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181821876 | chr6:141712864-141712865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532122597 | chr6:141712878-141712879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547547435 | chr6:141712940-141712941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187031167 | chr6:141712994-141712995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191105552 | chr6:141713023-141713024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548498546 | chr6:141713033-141713034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563470227 | chr6:141713044-141713045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569170717 | chr6:141713098-141713099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558795399 | chr6:141713119-141713120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576857432 | chr6:141713143-141713144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534683970 | chr6:141713190-141713191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548869651 | chr6:141713192-141713193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373270359 | chr6:141713226-141713227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17070787 | chr6:141713234-141713235 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs542263280 | chr6:141713250-141713251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560935788 | chr6:141713261-141713262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367613964 | chr6:141713306-141713307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576153492 | chr6:141713403-141713404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543762733 | chr6:141713414-141713415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565161724 | chr6:141713418-141713419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17070789 | chr6:141713469-141713470 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs547412948 | chr6:141713470-141713471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559254338 | chr6:141713487-141713488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7746931 | chr6:141713518-141713519 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs6570460 | chr6:141713549-141713550 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs7746952 | chr6:141713558-141713559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537632575 | chr6:141713597-141713598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73577529 | chr6:141713617-141713618 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs71811514 | chr6:141713637-141713638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538042927 | chr6:141713642-141713643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368818493 | chr6:141713797-141713798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111399910 | chr6:141713827-141713828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534745166 | chr6:141713847-141713848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552953429 | chr6:141713850-141713851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574736758 | chr6:141713877-141713878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs535593643 | chr6:141713920-141713921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10570652 | chr6:141713941-141713942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565993382 | chr6:141713943-141713944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150308962 | chr6:141713946-141713947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557401125 | chr6:141713987-141713988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554765973 | chr6:141713997-141713998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141229089 | chr6:141714009-141714010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200003054 | chr6:141714010-141714011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6934518 | chr6:141714012-141714013 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:141707800-141715800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr6:141711200-141712800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr6:141711600-141715400 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr6:141712800-141713200 | Enhancers | Fetal Brain Male | brain |
5 | chr6:141715000-141715400 | Active TSS | HepG2 | liver |
6 | chr6:141715400-141715600 | Flanking Active TSS | HepG2 | liver |
7 | chr6:141715600-141716400 | Flanking Bivalent TSS/Enh | HepG2 | liver |
8 | chr6:141715800-141716200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr6:141715800-141717200 | Strong transcription | iPS DF 6.9 Cell Line | embryonic stem cell |